Independent/Evidence-based/Sources: NIH ODS + DRILast reviewed February 2026
caredoctorevidence-based

Folate forms

Folic Acid vs Folate vs Methylfolate: Forms, MTHFR, and Who Needs Which

A plain-language breakdown of the three main forms of vitamin B9, what the MTHFR gene variant means for supplementation, and how to choose wisely.

Folic Acid vs Folate vs Methylfolate: Forms, MTHFR, and Who Needs Which

Folate, folic acid, and methylfolate are all forms of vitamin B9, but they behave differently in the body and suit different needs. Understanding those differences can help you have a more informed conversation with your doctor or pharmacist before choosing a supplement.

What Is Folate?

Folate is the naturally occurring form of vitamin B9 found in foods such as dark leafy greens, legumes, eggs, and citrus fruits. According to the NIH Office of Dietary Supplements (ODS), folate acts as a coenzyme in single-carbon transfer reactions that are essential for DNA and RNA synthesis, amino acid metabolism, and normal cell division. One especially important role is supporting the conversion of homocysteine to methionine, which feeds into the production of S-adenosyl-methionine, a key methyl donor used throughout the body.

The NIH ODS notes that folate naturally present in food is not considered harmful and has no established upper intake level. It is absorbed in the small intestine, but bioavailability from food is somewhat lower and more variable than from synthetic forms.

What Is Folic Acid?

Folic acid is the synthetic, oxidized form of vitamin B9 used in most dietary supplements and added to fortified foods such as bread, cereal, and pasta. It is more stable than food folate and is generally well absorbed. However, folic acid must be converted by the body into its active usable form through several enzymatic steps, including one carried out by an enzyme called dihydrofolate reductase.

The adult Recommended Dietary Allowance for folate is 400 micrograms of Dietary Folate Equivalents (mcg DFE) per day, as reported by the NIH ODS. The Tolerable Upper Intake Level for synthetic folic acid from supplements and fortified foods is 1,000 mcg per day for adults. The NIH ODS advises staying at or below that limit unless a healthcare provider recommends otherwise.

A clinically important safety note from the NIH ODS: high folic acid intake can mask a vitamin B12 deficiency by correcting the blood changes it causes while allowing irreversible nerve damage to progress undetected. Anyone concerned about B12 status should speak with a clinician before taking high-dose folic acid.

What Is Methylfolate (5-MTHF)?

Methylfolate, often labeled as 5-methyltetrahydrofolate or 5-MTHF, is the biologically active form that circulates in the bloodstream and crosses into cells and the brain. It is the end product of the conversion pathway that folic acid and food folate must go through before the body can use them. Because it is already in its active form, methylfolate does not require the same enzymatic processing steps that folic acid does.

Methylfolate supplements are available over the counter and are sometimes marketed specifically toward people with the MTHFR gene variant, discussed below. Please note that dietary supplements, including methylfolate, are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA.

The MTHFR Gene Variant: What It Means

MTHFR stands for methylenetetrahydrofolate reductase, an enzyme that performs one of the final steps in converting folate into its active 5-MTHF form. Variants in the MTHFR gene, most commonly C677T and A1298C, can reduce this enzyme's activity. Reduced activity means the conversion from folic acid to active methylfolate is less efficient.

Carrying one or two copies of an MTHFR variant is relatively common in the general population. Some people with reduced MTHFR activity may have higher homocysteine levels or lower circulating folate, though the clinical significance varies widely between individuals. If you have been told you carry an MTHFR variant, talk with your doctor before changing your supplement routine. They can review your full health picture and order relevant lab work if appropriate.

The rationale behind recommending methylfolate for people with MTHFR variants is that it bypasses the conversion step that is less efficient in those individuals. However, research on whether methylfolate supplementation produces meaningfully better outcomes in this population compared to standard folic acid is still developing, and a clinician is the right person to guide that decision.

Evidence for Key Health Outcomes

The NIH ODS grades the evidence for folate and its forms across several health areas:

  • Neural tube defects (Strong evidence): Adequate folic acid intake before conception and in early pregnancy is associated with a reduced risk of neural tube defects such as anencephaly and spina bifida. This is why public health guidelines recommend 400 mcg of folic acid daily for people who could become pregnant.
  • Stroke risk (Moderate evidence): Folate supplementation, alone or combined with other B vitamins, is associated with a reduced risk of stroke, particularly in populations with low folate status.
  • Cancer (Limited evidence): Folate naturally present in food may be associated with a lower risk of some cancers, while high-dose folic acid supplementation may have complex or potentially harmful effects. The NIH ODS rates this evidence as limited.
  • Depression (Limited evidence): Some research suggests folate supplements, particularly 5-MTHF, may improve depression or enhance antidepressant response. Evidence is rated limited and this is not a substitute for professional mental health care.
  • Cognitive function and dementia (Insufficient evidence): Current evidence is insufficient to conclude that folic acid supplementation improves cognitive function or prevents dementia or Alzheimer's disease.
  • Autism spectrum disorder (Insufficient evidence): Evidence that periconceptional folic acid reduces autism risk in offspring is currently rated insufficient by the NIH ODS.

Drug Interactions to Know

The NIH ODS identifies several important interactions between folate supplements and medications. Always talk to your doctor or pharmacist before combining supplements with any prescription drug.

  • Methotrexate: Folate supplements can interfere with methotrexate when it is used to treat cancer, because methotrexate works partly by inhibiting dihydrofolate reductase. Consult your provider before supplementing.
  • Antiepileptic medications such as phenytoin, carbamazepine, and valproate can reduce blood folate levels, and folate supplements can in turn reduce blood levels of these medications.
  • Sulfasalazine (used for ulcerative colitis) inhibits intestinal folate absorption and can cause folate deficiency.

Who May Benefit From Each Form

For most healthy adults, getting 400 mcg DFE daily through a varied diet and a standard multivitamin containing folic acid is sufficient. People who are pregnant or planning to become pregnant are advised to take folic acid specifically, as the strong evidence base for neural tube defect prevention is built on folic acid studies. People with confirmed MTHFR variants, those who have had difficulty maintaining adequate folate levels, or those who prefer to avoid synthetic folic acid may discuss methylfolate with their provider as an alternative. Food folate remains a valuable source for everyone and carries no upper intake limit.

All population reference values in this guide come from the NIH Office of Dietary Supplements. For personal dosing guidance, please consult a licensed clinician or pharmacist.

Sources